SCHEMBL7900933

SCHEMBL7900933

O=C(C1=CC=C(c2ccc(F)cc2)CC1)N1CCC(C(=O)NNc2ccc(F)cc2)(c2ccc(F)cc2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.37
HSD11B1 P28845 2/20 0.37
HDAC1 Q13547 1/20 0.36
KMT2A Q03164 1/20 0.35
PTPN1 P18031 1/20 0.34
IDO1 P14902 4/20 0.33
CYP2C9 P11712 2/20 0.33
OPRM1 P35372 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32
ALOX12 P18054 1/20 0.32
OPRL1 P41146 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7902298 0.85 P2RX7 (0.41) P2RX7HSD11B1KMT2AIDO1ALDH1A1
SCHEMBL3107003 0.83 PTPN1 (0.50) P2RX7HSD11B1HDAC1KMT2APTPN1
SCHEMBL3110203 0.78 HSP90AA1 (0.47) HSD11B1HDAC1PTPN1IDO1
SCHEMBL7900928 0.78 PTPN1 (0.46) HSD11B1HDAC1KMT2APTPN1ALDH1A1
SCHEMBL7907727 0.78 SLC6A7 (0.50) HSD11B1KMT2APTPN1HPGDCYP1A2
SCHEMBL7908417 0.77 KIT (0.40) KMT2ACYP2C9ALDH1A1CYP1A2CYP3A4
SCHEMBL3106971 0.76 PTPN1 (0.45) HSD11B1HDAC1KMT2APTPN1IDO1
SCHEMBL3227686 0.73 CYP3A4 (0.48) P2RX7KMT2APTPN1CYP2C9ALDH1A1
SCHEMBL7899679 0.73 AKR1C3 (0.51) KMT2AALDH1A1MAPTGAAALOX12
SCHEMBL13102505 0.71 HDAC1 (0.43) HSD11B1HDAC1KMT2APTPN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010106081-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-23 WO disclosed